Journals / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 1

Expression of Th17/Treg related molecules in gastric cancer tissues

Pages
45–51
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: IL-6, TGF-β1, FoxP3, and IL-17 may promote the progression of gastric cancer individually or jointly and have complex in-teractions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-β1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.
📊
Key Findings & Data:We investigated and analyzed the relevance of the proteins with the clinicopathological characteristics and the interactions among them in gastric cancer.Materials and Methods: A total 68 gastric cancer patients and 40 healthy controls were enrolled.
💡
Conclusion & Impact:Conclusion: IL-6, TGF-β1, FoxP3, and IL-17 may promote the progression of gastric cancer individually or jointly and have complex in-teractions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-β1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined. We investigated and analyzed the relevance of the proteins with the clinicopathological characteristics and the interactions among them in gastric cancer.Materials and Methods: A total 68 gastric cancer patients and 40 healthy controls were enrolled. Immunohistochemistry (IHC) as well as quantitative real-time reverse transcription- polymerase chain reaction (RT-PCR) was used to determine the expression levels of IL-6, TGF-β1, IL-17, and FoxP3 in the prepared tissues. Statistical analysis included ANOVA and chi-square test.Results: The expression levels of IL-6, IL-17, FoxP3, and TGF-β1 had significantly increased in cancer tissues compared to controls. Clinical staging of gastric cancer were correlated with the rise of IL-6, IL-17, FoxP3, and TGF-β1 levels expressed in cancer tissues. Theexpression level of TGF-β1 and IL-6 was positively related to that of IL-17 and FoxP3, similar to FoxP3 and IL-17 in gastric cancer tissues. Conclusion: IL-6, TGF-β1, FoxP3, and IL-17 may promote the progression of gastric cancer individually or jointly and have complex in-teractions.

🔖

Cite This Article

MENG, X., ZHU, S., DONG, Q., ZHANG, S., MA, J., ZHOU, C. (2018). Expression of Th17/Treg related molecules in gastric cancer tissues. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 1, 45–51. https://ajindex.com/articles/410141

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Yamada Y, Saito H, Ikeguchi M. Prevalence and clinical relevance of Th17 cells in patients with gastric cancer. J Surg Res 2012; 178: 685-91. [CrossRef] 31. Maruyama T, Kono K, Mizukami Y, et al. Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lympho-cytes, tumor-draining lymph nodes and peripheral blood lympho-cytes in patients with gastric cancer. Cancer Sci 2010; 101: 1947- 30. Chen Z, Ding J, Pang N, et al. The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients. Di-agn Pathol 2013; 8: 61. [CrossRef] 29. Gnerlich JL, Mitchem JB, Weir JS, et al. Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer. J Immunol 2010; 185: 4063-71. [CrossRef] 28. Zheng SG. Regulatory T cells vs Th17: differentiation of Th17 ver-sus Treg, are the mutually exclusive? Am J Clin Exp Immunol 2013; 2: 94-106. 27. Raghavan S, Quiding-Järbrink M. Regulatory T cells in gastro-intestinal tumors. Expert Rev Gastroenterol Hepatol 2011; 5: 489-501 26. Chia CY, Kumari U, Casey PJ. Breast cancer cell invasion medi-ated by Gα12 signaling involves expression of interleukins-6 and -8, and matrix metalloproteinase-2. J Mol Signal 2014; 9: 6. [CrossRef] 25. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic in-flammation. Nat Rev Drug Discov 2012; 11: 763-76. [CrossRef] 24. Zhao G, Zhu G, Huang Y, et al. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangio-genesis in gastric cancer. Oncol Rep 2016; 35: 1787-95. [CrossRef] 23. Szczepanik AM, Scislo L, Scully T, et al. IL-6 serum levels predict postoperative morbidity in gastric cancer patients. Gastric Cancer 2011; 14: 266-73. [CrossRef] 22. Ruzzo A, Catalano V, Canestrari E, et al. Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy. BMC Cancer 2014; 14: 357. [CrossRef] 21. Kononova TE, Urazova OI, Novitskii VV, Kolobovnikova YV, Churi-na EG, Zakharova PA. Factors of Th17 and treg lymphocyte differ-entiation in pulmonary tuberculosis. Bull Exp Biol Med 2015; 159: 201-4. [CrossRef] 20. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 2010; 40: 1830-5. [CrossRef] 19. Hagness M, Henjum K, Landskron J, et al. Kinetics and activation requirements of contact-dependent immune suppression by human regulatory T cells. J Immunol 2012; 188: 5459-66. [Cro